Intelligence · Clinical Pipeline
Tonix Pharmaceuticals Holding Pipeline
All ClinicalTrials.gov programs at Tonix Pharmaceuticals Holding — phase, modality, and trial IDs.
- Programs
- 9
Quick answer
Tonix Pharmaceuticals Holding has 9 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
TNX-102 SL
Tonix Pharmaceuticals Holding
Primary Fibromyalgia
1 trial -
TNX-102 SL
Tonix Pharmaceuticals Holding
PTSD
6 trials -
TNX-102 SL
Tonix Pharmaceuticals Holding
Fibromyalgia
2 trials -
TNX-102 SL 2.8mg
Tonix Pharmaceuticals Holding
Primary Fibromyalgia
1 trial -
TNX-102 SL 5.6 mg
Tonix Pharmaceuticals Holding
PTSD
1 trial -
TNX-102 SL Tablet 2.8 mg
Tonix Pharmaceuticals Holding
Primary Fibromyalgia
1 trial -
TNX-102 SL Tablet, 2.8 mg
Tonix Pharmaceuticals Holding
Fibromyalgia
1 trial -
TNX-102 SL Tablet, 2.8mg
Tonix Pharmaceuticals Holding
Fibromyalgia
1 trial -
TNX-102 SL Tablet, 5.6 mg
Tonix Pharmaceuticals Holding
Fibromyalgia
1 trial
Frequently asked questions
How many pipeline programs does Tonix Pharmaceuticals Holding have?
9 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs